AMYGDALA vs Ikko Health
AMYGDALA vs Ikko Health, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: AMYGDALA is on 31/100 and Ikko Health on 45/100.
Where each one leads
AMYGDALA
- agent readiness: 50/100 against 21/100
- headcount growth: +74.8% against +12.7%
Ikko Health
- our overall score: 45/100 against 31/100
- headcount: 15 against 9
- LinkedIn following: 67 against 9
At a glance
| Measure | AMYGDALA | Ikko Health |
|---|---|---|
| What it is | Developing AI-driven technology for mental health treatments, focusing on PTSD. | Transforming healthcare by turning scientific fiction into scientific facts. |
| Category | Healthcare, PTSD, Mental Health, Personalized | Healthcare, HealthTech, MedTech, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2017 | 2021 |
| Headquarters | Tel Aviv, Israel | London, United Kingdom |
| Status | Inactive | Inactive |
Size, funding and growth
| Measure | AMYGDALA | Ikko Health |
|---|---|---|
| Employees | 9 | 15 |
| Headcount growthLast 12 months | +74.8% | +12.7% |
| Total funding | Not published | $1.0M |
| Latest round | Not published | Seed |
| LinkedIn followers | 9 | 67 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | AMYGDALA | Ikko Health |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 31/100 | 45/100 |
| Traction | 10/100 | 42/100 |
| Team | 60/100 | 50/100 |
| Search visibility | 15/100 | 25/100 |
| Quality | Not published | 48/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 1/100 | Not published |
AMYGDALA vs Ikko Health: common questions
Which is better, AMYGDALA or Ikko Health?
On our 0-100 score Ikko Health rates higher (45/100 against 31/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do AMYGDALA and Ikko Health compare on the numbers?
AMYGDALA leads on agent readiness (50/100 against 21/100), headcount growth (+74.8% against +12.7%). Ikko Health leads on our overall score (45/100 against 31/100), headcount (15 against 9), LinkedIn following (67 against 9).
Read the full AMYGDALA review and pricing or the Ikko Health review and pricing. You can also browse other AMYGDALA alternatives we track.